Evidence map›Paper›PMID 38281112›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2024

Improving large language models for clinical named entity recognition via prompt engineering.

Yan Hu, Qingyu Chen, Jingcheng Du, Xueqing Peng, Vipina Kuttichi Keloth, Xu Zuo, Yujia Zhou, Zehan Li, Xiaoqian Jiang, Zhiyong Lu and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 2 pooled it
88.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 2 syntheses or guidelines pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yan HuMcWilliams School of Biomedical Informatics, Houston, TX, United States.ORCID 0009-0008-2413-5918
Qingyu ChenSection of Biomedical Informatics and Data Science, School of Medicine, Yale University, New Haven, CT, United States.
Jingcheng DuMcWilliams School of Biomedical Informatics, Houston, TX, United States.ORCID 0000-0002-0322-4566
Xueqing PengSection of Biomedical Informatics and Data Science, School of Medicine, Yale University, New Haven, CT, United States.
Vipina Kuttichi KelothSection of Biomedical Informatics and Data Science, School of Medicine, Yale University, New Haven, CT, United States.
Xu ZuoMcWilliams School of Biomedical Informatics, Houston, TX, United States.
Yujia ZhouMcWilliams School of Biomedical Informatics, Houston, TX, United States.ORCID 0000-0003-0889-2261
Zehan LiMcWilliams School of Biomedical Informatics, Houston, TX, United States.
Xiaoqian JiangMcWilliams School of Biomedical Informatics, Houston, TX, United States.ORCID 0000-0001-9933-2205
Zhiyong LuNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, United States.
Kirk RobertsMcWilliams School of Biomedical Informatics, Houston, TX, United States.
Hua XuSection of Biomedical Informatics and Data Science, School of Medicine, Yale University, New Haven, CT, United States.
Museum of Fine Arts, Houston · USYale University · USNational Institutes of Health · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Open Health Natural Language Processing CollaboratoryU01TR002062 · NCATS · MAYO CLINIC ROCHESTER · PI JIANG, XIAOQIAN, LIU, HONGFANG · 2017 to 2021
$7.6M
Leveraging Longitudinal Data and Informatics Technology to Understand the Role of Bilingualism in Cognitive Resilience, Aging and DementiaR01AG080429 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Michelle L Dossett, HUA XU · 2023 to 2026
$5.5M
Semi-structured Information Retrieval in Clinical Text for Cohort IdentificationR01LM011934 · NLM · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HERSH, WILLIAM R, LIU, HONGFANG · 2014 to 2025
$5.1M
Finding Combinatorial Drug Repositioning Therapy For Alzheimer'S Disease And Related DementiasR01AG066749 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JIANG, XIAOQIAN, ZHENG, WENJIN JIM · 2020 to 2024
$4.4M
Decentralized differentially-private methods for dynamic data release and analysisR01LM013712 · NLM · YALE UNIVERSITY · PI JIANG, XIAOQIAN, OHNO-MACHADO, LUCILA · 2022 to 2025
$2.5M
Facilitate Observational Studies of Alzheimer's Disease and Alzheimer's Disease-Related Dementias Using Ontology and Natural Language ProcessingRF1AG072799 · NIA · YALE UNIVERSITY · PI LIU, HONGFANG, TAO, CUI · 2021 to 2021
$2.4M
Facilitate Observational Studies of Alzheimer's Disease and Alzheimer's Disease-Related Dementias Using Ontology and Natural Language ProcessingR01AG072799 · NIA · YALE UNIVERSITY · PI HONGFANG LIU, Cui Tao · 2025 to 2026
$1.7M
Fine-Grained Spatial Information Extraction For Radiology ReportsR21EB029575 · NIBIB · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ROBERTS, KIRK EDWARD · 2020 to 2022
$892k
Use of NLP to Extract Risk Indicators for Immunologic Disease from the Text of EHRs (UNIITE)R21AI164100 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI RIDER, NICHOLAS L, ROBERTS, KIRK EDWARD · 2022 to 2024
$379k
Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoproteinF31CA180012 · NCI · HARVARD MEDICAL SCHOOL · PI GWIN, TYSHIA KYREE · 2014 to 2016
$101k
Cancer Prevention and Research Institute of Texas RR180012National Science Foundation 2124789NCATS NIH HHS U01 TR002062NCATS NIH HHS UL1 TR001863NIAID NIH HHS R21 AI164100NIA NIH HHS 1RF1AG072799NIA NIH HHS R01 AG066749NIA NIH HHS R01 AG072799NIA NIH HHS R01 AG080429NIA NIH HHS RF1 AG072799NIBIB NIH HHS R21 EB029575NIH HHS R21EB029575NLM NIH HHS R01 LM011934NLM NIH HHS R01 LM013712
6 · The paper itself

Abstract

importanceThe study highlights the potential of large language models, specifically GPT-3.5 and GPT-4, in processing complex clinical data and extracting meaningful information with minimal training data. By developing and refining prompt-based strategies, we can significantly enhance the models' performance, making them viable tools for clinical NER tasks and possibly reducing the reliance on extensive annotated datasets.

objectivesThis study quantifies the capabilities of GPT-3.5 and GPT-4 for clinical named entity recognition (NER) tasks and proposes task-specific prompts to improve their performance. MATERIALS AND

methodsWe evaluated these models on 2 clinical NER tasks: (1) to extract medical problems, treatments, and tests from clinical notes in the MTSamples corpus, following the 2010 i2b2 concept extraction shared task, and (2) to identify nervous system disorder-related adverse events from safety reports in the vaccine adverse event reporting system (VAERS). To improve the GPT models' performance, we developed a clinical task-specific prompt framework that includes (1) baseline prompts with task description and format specification, (2) annotation guideline-based prompts, (3) error analysis-based instructions, and (4) annotated samples for few-shot learning. We assessed each prompt's effectiveness and compared the models to BioClinicalBERT.

resultsUsing baseline prompts, GPT-3.5 and GPT-4 achieved relaxed F1 scores of 0.634, 0.804 for MTSamples and 0.301, 0.593 for VAERS. Additional prompt components consistently improved model performance. When all 4 components were used, GPT-3.5 and GPT-4 achieved relaxed F1 socres of 0.794, 0.861 for MTSamples and 0.676, 0.736 for VAERS, demonstrating the effectiveness of our prompt framework. Although these results trail BioClinicalBERT (F1 of 0.901 for the MTSamples dataset and 0.802 for the VAERS), it is very promising considering few training samples are needed. DISCUSSION: The study's findings suggest a promising direction in leveraging LLMs for clinical NER tasks. However, while the performance of GPT models improved with task-specific prompts, there's a need for further development and refinement. LLMs like GPT-4 show potential in achieving close performance to state-of-the-art models like BioClinicalBERT, but they still require careful prompt engineering and understanding of task-specific knowledge. The study also underscores the importance of evaluation schemas that accurately reflect the capabilities and performance of LLMs in clinical settings.

conclusionWhile direct application of GPT models to clinical NER tasks falls short of optimal performance, our task-specific prompt framework, incorporating medical knowledge and training samples, significantly enhances GPT models' feasibility for potential clinical applications.

Indexed as

Electronic Health RecordsNatural Language ProcessingData MiningHumansclinical named entity recognitionGPT-3.5GPT-4large language modelsprompt engineering

Identifiers

PMID38281112
PMCPMC11339492
OpenAlexW4391292768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.